Action signal — 🔍 Research

Surfaced by the 2026-10-16 actions digest.

Action: 🔍 Research (LOW) RSI: 18.1

Why this is in actions

Enliven lost its 200-day after a steep month. Clinical-stage veto. News pulled Oct 13 holds nothing dated Oct 12–16. Report listed Nov 11 (provider date). 8-K filed Oct 14, unread.

Trade Summary

Stub — 🔍 Research means more research needed before action.

Sources

• Actions digest: 2026-10-16-actions-daily-digest
• Original row: | **ELVN** | $37.32 | reclaim of the 200-day ($41.62) | **18.1** | **-24.02%** | 71.59% | -10.3% | 2026-10-16 | momentum board | 🔍 Research | Enliven lost its 200-day after a steep month. Clinical-st
• Price truth: summaries